Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. - Wikidata - wikimedia - TriplyDB

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

http://www.wikidata.org/entity/Q33733675

about

Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature Utility of susceptibility-weighted imaging in Parkinson's disease and atypical Parkinsonian disorders Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options Dystonia in progressive supranuclear palsy Clinical genetics of familial progressive supranuclear palsy.Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy Parkinsonism and tremor disorders. A clinical approach.A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy Typical or atypical progressive supranuclear palsy: a comparative clinicopathologic study of three Chinese cases.Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy.Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.Levodopa responsiveness in disorders with parkinsonism: a review of the literature.Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C.Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.Voxel-based morphometry in autopsy proven PSP and CBD Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study.Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.Fifty years of progressive supranuclear palsy.Progressive supranuclear palsy: clinical and pathological diagnosis.A Review of Treatment Options for Progressive Supranuclear Palsy.Time Trends in the Incidence of Parkinson Disease.Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.Freezing of gait in postmortem-confirmed atypical parkinsonism.Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center.Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration.Corticobasal syndrome with tau pathology.A two-fold difference in the age-adjusted prevalences of Parkinson's disease between the island of Als and the Faroe Islands.Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.Differentiation of PA from early PSP with different patterns of symptoms and CBF reduction.Parkinson disease with and without Dementia: A prevalence study and future projections.Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of parkinsonism.Clinical correlates of the pathology underlying parkinsonism: a population perspective.Atypical progressive supranuclear palsy with corticospinal tract degeneration.Saccades in progressive supranuclear palsy - maladapted, irregular, curved, and slow.

P2860

Q26801152-50505F26-B227-49A5-B5F6-5C2786BA2F4E Q28066787-DB8D8203-158A-4E47-94F1-C63E2CC5E26C Q28072101-B4EA69FA-9F29-4BFB-A08A-30DB726F3D58 Q28379589-D7EF60AC-6703-4B32-88EF-B74AC51D6B82 Q33178604-0494AC8B-6046-4E3A-BF3E-D1732EE3C0BA Q33735302-F3DE460F-B1A1-4DCF-87D0-D7CEC323495F Q34604164-76C6021A-9121-407D-A61E-5E1B53AC69F6 Q34804035-D1DBA08A-9842-4E9A-9903-97E51F402B01 Q34994716-605B30D2-96B3-4565-97D5-937437C1988F Q35144812-90E2EBDC-4FE0-4A68-9B51-EC9D22152051 Q36110771-7F162934-63CF-486B-BE74-62F368BC02B9 Q36142223-3B8921A5-3739-43D2-927F-B0DE55621745 Q36318598-89C5EDE7-E840-4B29-90A8-D6799FF8462E Q36834251-FF7730F8-EC4E-40E0-B458-937A6C1B3424 Q36885378-487F2ABA-CFA5-411A-AEDE-8B2C52D33A2B Q37001365-9A5AC272-5709-4AA0-AE49-A677B9A3B7F2 Q37243463-59096B3C-1229-46FA-914F-359A55F7E51F Q37653322-3C68273A-9F62-4CA1-A358-04B4E4CAACDA Q38084252-D2E87F94-14AD-4E23-A4BB-9166715520E7 Q38135221-D15E2A61-54F8-4BA8-8049-B3D68358A559 Q38166808-BD13A186-73EB-4137-ADCE-71481F6FBA84 Q38843694-FE2D4686-6897-4924-923B-52BB113904EE Q38870766-BABEB428-61A8-4FA6-80A9-13083AC90B03 Q40069625-DC19BE45-A5D8-4C2A-81DB-09F1AD929F2E Q40201095-E69C7DCE-0376-4822-A276-26AFE9391CCF Q40629446-72817383-E0EF-460A-8DEB-E77168A5022A Q41055604-000997F5-08B7-45D0-96FC-9AD1DE57850D Q41847841-8E07E331-39C6-43C1-AECB-CFEA4BBF27C2 Q42359354-2A877EA2-747E-4655-9BFF-E30E60BC627F Q42505583-3449EFDF-CF3D-4E02-9B85-C852D135A26D Q42508033-001BCAF9-B1C4-48E4-9B6A-1EA4DACBFA5B Q43693155-3F7925B6-4224-495C-B226-F08C1D475963 Q44060161-DCA53E10-C8FC-4A9D-A374-BA0E637933A8 Q46437425-9A487EC5-C853-46E1-8CDC-3F0C5A5D0405 Q47720092-6B0DCEE0-9243-43EF-B4FB-1FD0D79E2377 Q48258693-A0600DD2-CECA-446A-8692-F61FB77F7B06 Q48476359-868F2BFF-285C-49F3-B5BA-8B50343A882E Q48543536-25524E57-6502-48E0-A4DC-F7E09B981B5E Q50049072-45FA649A-1FC8-4823-9300-74EFF0634B1E

P2860

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

http://www.wikidata.org/entity/Q33733675

description

1995 nî lūn-bûn

@nan

1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

@ast

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

@en

type

label

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

@ast

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

@en

prefLabel

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

@ast

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

@en

P1433

Q33733675-9C538589-4CB9-4C0F-AD5D-3844623CE12B

P1476

Q33733675-4142BF67-8A36-4827-8B05-2A4E14897BBD

P2093

Q33733675-2A4A7514-7BE2-460E-A032-2EF22910CBBF

Q33733675-68325461-67A2-42C4-800F-D5C869A6EFE8

Q33733675-C75465D2-06B2-4A42-8B8E-9E87E20DAD5B

Q33733675-D7232EFF-6419-49E4-8133-8947924B03BB

P2860

Q33733675-0749C20A-1A0D-4E6A-820A-DDE3FEEA664C

Q33733675-11571805-BA5B-4308-84BA-105764585F3B

Q33733675-26B1F97A-F831-4183-BCB4-D9894799BF25

Q33733675-3117D28A-04AA-4949-8945-0CE4F2057E10

Q33733675-33E1D88B-3328-45D3-8F75-85058200D3B5

Q33733675-3C494F0E-6496-4C3E-9643-D14BF3D82000

Q33733675-4D02128C-A7E8-453C-A1D6-046D32CA437E

Q33733675-57445176-752D-422A-8905-0320D7C28E9C

Q33733675-5E5AC5FA-7782-499A-8FEA-C111AF486216

Q33733675-7D3EFE11-3922-4EF1-B7E1-A9272942DF20

P304

Q33733675-9B7C2E7B-3999-4DAF-9070-098B616D39D4

P31

Q33733675-C19866E3-E8A0-49D5-853D-F14019236937

P356

Q33733675-46A4CB37-7F0F-4DFC-823C-D3D8E36993DD

P407

Q33733675-7B5B161B-7E12-45C7-B94F-B0E40779627D

P433

Q33733675-A6FBC479-D735-4C20-89B9-8CAD54F1C2DF

P478

Q33733675-9A949E8F-3E22-46E1-8F09-DE9258A9CD00

P577

Q33733675-E85BC84C-FD9C-46D1-83F4-E4BAFA5A2EB7

P5875

Q33733675-E1C34AF8-79AF-4D2C-9FB4-0F0032BBAD28

P698

Q33733675-5257C673-3760-4701-95DE-853383D4F398

P932

Q33733675-18AF04E6-987B-4A0F-B899-ECB32B8099C6

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

@en

P2093

Ahlskog JE

http://www.w3.org/2001/XMLSchema#string

Collins SJ

http://www.w3.org/2001/XMLSchema#string

Maraganore DM

http://www.w3.org/2001/XMLSchema#string

Parisi JE

http://www.w3.org/2001/XMLSchema#string

P2860

Ageing and Parkinson's disease: substantia nigra regional selectivity

Diffuse Lewy body disease presenting with a supranuclear gaze palsy

Multiple system atrophy--the nature of the beast.

Corticodentatonigral degeneration with neuronal achromasia.

Restriction in upward gaze with advancing age

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Prevalence and natural history of progressive supranuclear palsy.

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

Cortical-basal ganglionic degeneration.

Further observations in progressive supranuclear palsy.

P304

167-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.58.2.167

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

1995-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15322074

http://www.w3.org/2001/XMLSchema#string

P698

7876846

http://www.w3.org/2001/XMLSchema#string

P932

1073312

http://www.w3.org/2001/XMLSchema#string